Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist
For those living with type 2 diabetes, semaglutide has been shown to lower blood sugar levels and assist in weight management by improving insulin sensitivity
The first step is a thorough evaluation to identify contributing factors
Each increase brings stronger appetite suppression and potentially more GI side effects
US$ 23.63
US$ 21.51
US$ 21.15
US$ 26.97
US$ 23.65
US$ 29.89
:max_bytes(150000):strip_icc():focal(742x202:744x204)/GLP1-Now-Affordable-052926-1d50af52042b44b79fc71edef280243d.jpg)
